Haemophilia trials in Croatia
7 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleOpen-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
- Where
- Grad Zagreb
- Age
- 1 year to 74 years
- People
- 245 worldwide
- Run by
- Pfizer
See details and how to joinNCT05145127 · EU 2022-500470-33-00 - Phase 4Taking peopleTreatment of Hemophilia A Patients With FVIII Inhibitors
- Where
- Zagreb
- People
- 120 worldwide
- Run by
- Emory University
See details and how to joinNCT04023019 · EU 2024-516741-39-00 - No phaseEnrolling by invitationA Study Following Males With Haemophilia B on Prophylaxis With Refixia/REBINYN
- Where
- Zagreb
- People
- 60 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT03745924 - No phaseTaking peopleEfficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients
- Where
- Zagreb
- People
- 200 worldwide
- Run by
- Octapharma
See details and how to joinNCT03695978 - Phase 4Taking peopleNuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study
- Where
- Zagreb
- Age
- 12 years and over
- People
- 28 worldwide
- Run by
- Octapharma
See details and how to joinNCT05935358 - No phaseEnrolling by invitationA Study Following Males With Haemophilia A on Prophylaxis With Esperoct®
- Where
- Zagreb
- People
- 60 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT04574076 - Phase 4Taking peopleNuwiq for Perioperative management Of patients With haemophilia A on Emicizumab Regular prophylaxis study (NuPOWER)
- Where
- Grad Zagreb
- People
- 45 worldwide
- Run by
- Octapharma AG
See details and how to join2022-502060-21-00 · EU 2022-502060-21-00